Hadhs molecules as modifiers of the p21 pathway and methods...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/53 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2453871

Human HADH genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of HADH are provided.

Selon cette invention, les gènes HADH humains ont été identifiés comme étant des modulateurs de la voie p21 et constituent donc des cibles thérapeutiques pour des troubles associés à une déficience de la fonction p21. Cette invention porte sur des méthodes d'identification de modulateurs de p21 consistant à rechercher les agents responsables de la modulation de l'activité des HADH.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hadhs molecules as modifiers of the p21 pathway and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hadhs molecules as modifiers of the p21 pathway and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hadhs molecules as modifiers of the p21 pathway and methods... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1956239

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.